Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Triglycerides as a biological marker of repeated re-hospitalization resulting from deliberate self-harm in acute psychiatry patients: a prospective observational study

BMC Psychiatry201414:54

https://doi.org/10.1186/1471-244X-14-54

Received: 13 June 2013

Accepted: 21 February 2014

Published: 25 February 2014

Abstract

Background

Biological factors have been associated with deliberate self-harm (DSH) but have not been integrated with clinical factors in routine risk assessments.

This study aimed to examine the incremental validity of lipid levels and platelet serotonin when combined with psychosocial factors in risk assessments for repeated admissions due to DSH.

Methods

In this prospective observational study of 196 acutely admitted patients, results of blood tests performed upon admission and the MINI Suicidal Scale and psychosocial DSH risk factor assessments performed at discharge were compared with the incidence of DSH recorded during the first 3 and 12 months after discharge.

Results

High triglyceride levels were found to be a significant marker for patients admitted 3 or more times due to DSH (repeated DSH, DSH-R) when tested against other significant risk factors. When all (9) significant univariate factors associated with 12-month post-discharge DSH-R were analyzed in a multivariate logistic regression, the MINI Suicidal Scale (p = 0.043), a lack of insight (p = 0.040), and triglyceride level (p = 0.020) remained significant. The estimated 12-month area under the curve of the receiver operator characteristic (ROC-AUC) for DSH-R was 0.74 for triglycerides, 0.81 for the MINI, 0.89 for the MINI + psychosocial factors, and 0.91 for the MINI + psychosocial factors + triglycerides. The applied multifaceted approach also significantly discriminated between 12-month post-discharge DSH-R patients and other DSH patients, and a lack of insight (p = 0.047) and triglycerides (p = 0.046) remained significant for DSH-R patients in a multivariate analysis in which other DSH patients served as the reference group (rather than non-DSH patients).

Conclusion

The triglyceride values provided incremental validity to the MINI Suicidal Scale and psychosocial risk factors in the assessment of the risk of repeated DSH. Therefore, a bio-psychosocial approach appears promising, but further research is necessary to refine and validate this method.

Keywords

Prospective Suicidal behavior Deliberate self-harm (DSH) Bio-psychosocial Triglycerides Self-report risk scale MINI suicidal scale Lipids

Background

Many risk factors contribute to suicide and self-harming behavior [1]. Performing a full risk assessment of such behavior is therefore time-consuming and requires expertise [2]. However, acute settings are characterized by time pressure and high patient turnover. Screening instruments, such as the MINI Suicidal Scale, have been shown to help identify patients at risk for self-harm [3], and a 27-item scale based on 154 items from a collection of suicidal assessment instruments showed promise for the development of a new scale evaluating suicidal risk in settings in which time is limited [4].

Patients who are repeatedly hospitalized because of deliberate self-harm represent a special challenge for emergency units [5]. In a study of patients admitted to emergency wards after a suicide attempt, the Suicide Assessment Scale (SUAS, a 20-item scale) was found to perform well in screening for repeated suicide attempts in patients receiving ongoing psychiatric treatment but less well in screening for repeated suicide attempts in the entire study population [6]. A recent multicenter study showed that clinical decision rules based on 5 variables (gender, current psychiatric treatment, previous self-harm, antidepressant treatment, and/or self-poisoning with benzodiazepines) could be used to enhance risk assessment of repeated deliberate self-harm (DSH-R) in patients admitted to emergency units [7].

Biological factors have been associated with suicidal behavior [8, 9], and it has been suggested that a model that integrates feasible biological markers and clinical risk factors could optimize the assessment of suicide risk [10]. Meta-analyses have shown that the 5-hydroxyindolacetate levels in cerebrospinal fluid and a positive dexamethasone test (DST) associated with mood disorders are significant markers of prospective suicide risk and that combining these two methods increases predictive accuracy [10]. One study demonstrated that serum cholesterol concentrations may be combined with DST results to provide a clinically useful estimate of suicide risk in depressed patients [11]. However, with the exception of total cholesterol, these tests are difficult to integrate into routine clinical practice in acute settings. Many cross-sectional and retrospective studies have revealed a significant correlation between lipids and self-harm [1216]. However, two prospective studies found no associations between serum cholesterol levels in depressed patients and subsequent suicide attempts [17, 18].

In a prospective study examining different screening methods for deliberate self-harm risk during the first year after discharge from an emergency psychiatric ward, we found that (i) high triglyceride (TG) levels [19], (ii) the MINI Suicidal Scale [3], and (iii) patients’ own estimates of future risk (Self-report Risk Scale) [20] were significant predictors of self-harming behavior following discharge from an emergency psychiatric ward. The present research aimed to test the incremental validity of a biological marker (TG levels) when combined with other risk factors to identify patients at risk for repeatedly being hospitalized due to self-harming behavior.

Methods

An observational follow-up study was performed at the acute psychiatric ward of Aalesund Hospital in Norway, which serves a population of 125,000 individuals. The target group consisted of all patients who were acutely admitted from March 7, 2006, to March 7, 2007. Of these 489 patients, 254 (52%) provided written consent and were included in the study. Fifty-eight patients were lost to follow-up after discharge. Thus, the final study group consisted of 196 patients (40%) who were followed-up 1 year after discharge. The project was approved by the Regional Committee for Medical Research Ethics and the Ministry of Health and Care. Further information concerning the study methodology is included in previous reports [3, 19].

Consenting patients provided a fasting blood sample 1 to 3 days after admission. At discharge, the patients’ therapists in the acute ward scored them based on the MINI Suicidal Scale and the Self-report Risk Scale. Other baseline variables were obtained from medical records.

Follow-up at 3 and 12 months after discharge was conducted by the patients’ therapists at outpatient psychiatric clinics or district psychiatric wards. Patients discharged to the community were monitored by their psychiatric nurse in the acute ward. Self-harm episodes were recorded during the 0–3-, 4–6-, 7–9-, and 10–12-month periods. Information was collected from patients and collaterals and from inpatient and outpatient hospital records.

Baseline variables

Lipids and serotonin: Total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and TG levels were measured in fasting blood serum, and serotonin was measured in blood platelets [19]. The fasting period was from 12:00 PM until blood was drawn at 8:00-9:00 AM the next morning.

The MINI Suicidal Scale is a subscale of the MINI neuropsychiatric interview [21]. We used a short, 6-item version of this instrument. Each item is scored yes = 1 or no = 0. Items 1-5 evaluate whether an event has occurred during the last month. The 6 included items are as follows: (1) do you think that you would be better off dead or wish you were dead; (2) do you want to harm yourself or to hurt or injure yourself; (3) do you think about suicide; (4) do you have a suicide plan; (5) have you attempted suicide; and (6) in your lifetime, did you ever make a suicide attempt? The number of “yes” responses to the MINI items (0-6) was recorded for further analyses.

Self-report Risk Scale (SRS): Because of the lack of available instruments, the SRS was constructed for this study to measure patients’ judgment regarding their own subsequent risk of self-harming behavior [20]. Two questions were addressed to the patients at discharge: what is your opinion of the risk that you (A) will try to hurt or injure yourself without the intention of killing yourself, and (B) will try to kill yourself? For each question, the patient was given 7 response options: no risk, low risk, moderate risk, high risk, very high risk, do not know the risk, or will not answer about the risk. In this study, no risk was scored as 0 (negative), and the other 6 response options were scored as 1 (positive).

Information regarding gender, age, length of hospital stay, legal status, and ICD-10 diagnosis was obtained from hospital records. Violent behavior and violent victimization were recorded during follow-up in a parallel project performed at the same time [22] and determined from the hospital records, as were some items from the Violence Risk-10 (V-RISK-10) screening tool, including V6, a lack of insight into their illness; V9, unrealistic planning for the future; and V10, future stress exposure/vulnerability. Hopelessness has been identified as an important risk factor for self-harm [23], and at discharge, the patients’ experience of hopelessness for their own future was scored as “yes” or “no” by the therapist.

Outcome variables

The outcome measures included in the analysis were threats and attempts of suicide and threats and acts of non-suicidal self-injury (NSSI). A suicide attempt was defined as self-infliction of physical injury with the intention of killing oneself, and NSSI was defined as inflicting physical injury upon oneself without the intention of killing oneself [24]. Suicide attempts and NSSI were categorized as less severe (without the need for hospitalization) or severe (followed by hospitalization or fatality). All study subjects were scored as “No episodes”, “Yes – episode(s)”, or “Do not know”. To improve the statistical power, the analyses were performed by merging threats, less-severe acts, and severe acts of suicide and NSSI into one common variable: deliberate self-harm (DSH), which was coded as 0 (no self-harm), or 1 (suicidal or NSSI threat or attempt).

Some of the patients had both suicidal and NSSI behaviors at different times during follow-up, and it was difficult to categorize these behaviors into either the suicidal or NSSI group. Consequently, the patients were categorized into 3 groups; suicidal group, NSSI group, and suicidal + NSSI group [3, 25].

Results from the 4–6-month and 7–9-month follow-up periods did not add significant information. For clarity, results are only provided for short-term (0–3 months) and long-term (0–12 months) periods. Because psychosocial and biological risk factors may change over time, both the short- and long-term periods are of interest.

Statistical analysis

The data were analyzed using SPSS version 19.0. Chi-square tests were used to compare frequencies, and t-tests and one-way analysis of variance (ANOVA) were used for continuous variables. Binary logistic regression analyses were conducted to obtain univariate and multivariate effect sizes (odds ratio, OR). A block-enter procedure was used to monitor the progression of the chi-square test to examine whether each of the factors significantly added to the variance explained by the model. To address the relative importance of the various contributing factors, two R2 approximations (Cox & Snell R2 and Nagelkerke R2) were employed as the lower and upper limits of the extent to which total variance in DSH could be explained by the predictors.

Analysis of the area under the curve (AUC) of the receiver operating characteristic (ROC) was performed to assess the overall predictive accuracy of the models. The following predictive validity estimates were also computed: sensitivity (how many of the DSH patients displayed a positive test), specificity (how many patients without DSH displayed a negative test), positive predictive value (PPV, how many patients with a positive test exhibited DSH), negative predictive value (NPV, how many patients with a negative test did not exhibit DSH), number needed to assess (NNA, how many patients would need to be assessed to identify one true DSH patient, which is equal to 1/PPV), and the likelihood ratio (LR). The LR determines the extent to which the odds of an outcome (e.g., DSH) increase when a test is positive (LR+) and decrease when a test is negative (LR–). An LR + value of 3.0 signifies a 3-fold increase in the likelihood of DSH. For tests with only two outcomes (DSH or not), the LR + and LR– can be expressed as sensitivity/(1 – specificity) and (1-sensitivity)/specificity, respectively [26].

Results

A comparison between the follow-up sample (40%) and the other admitted patients (60%) is shown in Table 1.
Table 1

Comparison of follow-up and missing patients

 

Follow-up (n = 196)

Missing (n = 293)

p-value

Men

104 (53%)

158 (54%)

0.820

Mean age (years)

42.4

45.7

0.027

Mean hospital stay (days)

20

14

<0.001

Involuntary admittance

42 (21%)

63 (23%)

0.655

Mandatory aftercare

17 (8.6%)

22 (7.5%)

0.799

F1x substance abuse

30 (15%)

44 (15%)

0.898

F10 alcohol abuse

21 (11%)

29 (10%)

0.780

F2x psychotic disorders

29 (15%)

49 (17%)

0.703

F30-31 bipolar disorders

29 (15%)

24 (8.2%)

0.049

F32-39 depressive disorders

54 (28%)

66 (23%)

0.213

F4x anxiety disorders

38 (19%)

55 (19%)

0.704

F6x personality disorders

13 (6.6%)

13 (4.5%)

0.319

Feeling of hopelessness

24 (12%)

33 (14%)

0.484

DSH during hospital stay

14 (7.1%)

0

<0.001

Positive SRS rating

35 (20%)

28 (12%)

0.043

Positive MINI items at discharge (0-6)

2.4

1.8

0.004

Suicide attempt prior to admission

29 (15%)

24 (10%)

0.076

Suicide attempt ever

84 (45%)

67 (28%)

<0.001

Suicidal ideation prior to admission

92 (49%)

102 (42%)

0.130

Wish of self-harm prior to admission

73 (39%)

71 (29%)

0.031

Total cholesterol (mmol/liter)

5.0

5.1

0.876

Triglycerides (mmol/liter)

1.4

1.3

0.527

HDL (mmol/liter)

1.3

1.4

0.083

LDL (mmol/liter)

3.3

3.6

0.227

Platelet serotonina

3.5

3.2

0.685

Platelet serotoninb

0.85

0.82

0.922

DSH = deliberate self-harm; SRS = Self-report Risk Scale; MINI = the MINI Suicidal Scale; HDL = high-density lipoprotein; LDL = low-density lipoprotein.

anmol/109 platelets, not using serotonin reuptake inhibitors (SSRI, SNRI or TCA).

bnmol/109 platelets, using serotonin reuptake inhibitors.

Two patients took their lives during the follow-up [3], and 75 (36%) patients were recorded as exhibiting DSH at the 1-year follow-up, 52 of whom were hospitalized again because of DSH. Among these patients, 23 were re-hospitalized once; 11 underwent 2 re-hospitalizations; 7 experienced 3 re-hospitalizations; 5 underwent 4 re-hospitalizations; and 6 patients were subjected to 5 re-hospitalizations related to DSH. Patients exhibiting 3 or more DSH-related re-hospitalizations (repeated DSH, DSH-R) constituted 24% of the total sample of DSH patients and 9% of all patients but accounted for 83% of DSH-related re-hospitalizations and 44% of all re-hospitalizations. One DSH-R patient was recorded as only exhibiting suicidal attempts. The other 17 DSH-R patients were recorded as displaying at least 1 suicidal attempt and 1 NSSI at different times (suicidal + NSSI group). A comparison of the non-DSH patients, DSH-R patients, and patients with 1 or 2 DSH re-hospitalizations or post-discharge DSH episodes without hospitalization (1-2 DSH) is presented in Table 2. DSH-R was recorded for 13 patients within the first 3 months after discharge.
Table 2

Comparison of patients not showing deliberate self-harm (DSH) with patients exhibiting one or two DSH episodes and those displaying repeated DSH after discharge

Number of patients (N = 196)

No DSH

1-2 DSH

DSH-R

n = 121 (62%)

n = 57 (29%)

n = 18 (9%)

Males/females (%)

59/60 (50/50%)

36/24 (60/40%)

6/12 (33/67%)b*

Mean age, years [95% CI]

43 [40-46]

42 [38-45]

38 [31-45]

Mean hospital stay, days [95% CI]

22 [ 8-27]

20 [16-24]

12 [6-18]a*

Involuntary admissions

25 (21%)

12 (20%)

5 (28%)

Mandatory aftercare

10 (8.4%)

6 (10%)

1 (5.6%)

Inpatient DSH

4 (3%)

3 (5%)

7 (39%)a***b***

Hopelessness at discharge

11 (10%)

7 (13%)

6 (38%)a** b*

Lack of insight“

41 (35%)

30 (52%)a*

15 (83%)a*** b*

Unrealistic plans“

43 (37%)

35 (69%)a**

13 (72%)a**

Stress exposure“

61 (53%)

37 (64%)

11 (61%)

Positive MINI items [95%CI]“

1.9 [1.5-2.3]

3.0 [2.3-3.6]a**

4.1 [3.3-4.9]a***b*

Positive SRS ratings“

33 (30%)

26 (50%)a*

15 (83%)a*** b*

Violent offenders after discharge

21 (18%)

15 (25%)

8 (44%)a*

Victims of violence“

19 (17%)

14 (24%)

10 (56%)a*** b*

Main diagnoses

   

Substance misuse (F10-19)

19 (16%)

8 (13%)

3 (17%)

Psychoses (F20-29)

18 (15%)

9 (15%)

2 (11%)

Manic/bipolar disorders (F30-31)

19 (16%)

8 (14%)

2 (11%)

Depressive disorders (F32, F34.1)

37 (26%)

26 (15%)

0 a** b* f

Anxiety disorders (F40-49)

24 (20%)

11 (18%)

3 (17%)

Personality disorders (F60-62)

3 (3%)

3 (5%)

7 (39%)a*** b*** c

Blood measures

   

Total cholesterolmmol/l [95%CI]

4.9 [4.7-5.1]

5.3 [4.9-5.6]

5.3 [4.8-5.9]

LDL“

3.2 [3.0-3.3]

3.6 [3.3-3.9]

3.6 [3.0-4.1]

HDL“

1.3 [1.2-1.4]

1.3 [1.1-1.5]

1.2 [1.0-1.4]

Triglycerides“

1.2 [1.1-1.3]

1.4 [1.2-1.6]

2.1 [1.5-2.6]a***b*

Platelet serotonind

3.3 [2.6-3.8]

3.7 [2.4-5.1]

3.0 [1.9-4.1]

Platelet serotonine

0.88 [0.53-1.2]

0.72 [0.38-1.1]

0.79 [0.27-1.6]

DSH = deliberate self-harm; 1-2 DSH = one or two DSH episodes/re-admissions; R-DSH = three or more DSH re-admissions.

*p ≤ 0.05, ** p ≤ 0.01, ***p ≤ 0.001.

aSignificantly different from non-DSH patients.

bSignificantly different from 1-2 DSH patients.

cAll unstable (borderline) personality disorders.

dnmol/109 platelets [95% CI], not using serotonin reuptake inhibitors (SSRI, SNRI, or TCA).

enmol/109 platelets [95% CI], using serotonin reuptake inhibitors.

fTwo of the DSH-R patients had co-morbid diagnosis of unipolar depression.

For patients with suicidal behavior only, the odds ratios [95% CIs] for total cholesterol and TG associated with 12-month suicidal behavior were 1.3 [0.95-1.8] (p = 0.104) and 1.9 [1.1-3.5] (p = 0.026), respectively. The corresponding values for 12-month NSSI only were 1.2 [0.66-2.3] (p = 0.524) and 1.8 [0.69-4.7] (p = 0.234); for 12-month suicidal behavior + NSSI, the odds ratios for total cholesterol and TG were 1.3 [0.89-1.9] (p = 0.171) and 2.6 [1.4-4.9] (p = 0.003), respectively.

Eleven of the 18 DSH-R patients had 1 or 2 co-morbid psychiatric diagnoses, such as alcohol disorders (3 patients), mild intellectual disability (3), personality disorders (1 borderline and 1 unspecified), bipolar depression (2), unipolar depression (2), and anxiety disorders (2).

Univariate and multivariate predictive values

TG levels significantly predicted DSH-R at 12 months, with an OR [95% CI] of 4.2 [1.9-9.4] (p < 0.001). The 3-month OR was 3.2 [1.7-6.3] (p = 0.001). No other lipids were significant in the 1-2 DSH and DSH-R groups, and the platelet serotonin levels were also not significant.

The 3- and 12-month ORs [95% CIs] for the MINI for DSH-R were 1.7 [1.3-2.4] (p = 0.001) and 1.8 [1.3-2.4] (p < 0.001), respectively, and the corresponding values for SRS were 12 [2.5-54] (p = 0.002) and 12 [3.2-44] (p < 0.001).

When the 9 significant factors associated with post-discharge DSH-R at 12 months (see Table 2), including gender, hopelessness, inpatient DSH, a personality disorder (PD), violent victimization, a lack of insight, positive MINI items, SRS, and TG, were entered into multiple regression analyses, the lack of insight and TG were the only factors that remained significant.

Table 3 shows the results of the block-entry logistic regression analysis of the 9 significant factors and age. Age was not significant in the univariate analysis but is considered to be significantly associated with self-harm; therefore, age was entered into the analysis as the tenth factor. Gender, age, PD, and TG were entered in the first step of the analyses; hopelessness, inpatient DSH, victims of violence, and lack of insight were added in the second step; and MINI and SRS were added in the third step.
Table 3

Stepwise multivariate analyses of the significant factors of patients with three or more re-hospitalizations caused by DSH 12 months after discharge of index admission

   

Variance

 

Explained

 

OR [95% CI]

p

χ 2 (d.f.)

p

Variancea

Step 1

     

 Female

1.4 [0.32-6.5]

0.638

   

 Age

1.0 [0.96-1.05]

0.696

   

 Personality disorders

36 [4.8-274]

<0.001

   

 Triglycerides

3.4 [1.5-7.6]

0.004

   

Total variance of step 1

  

33 (4)

<0.001

24-44%

Step 2

     

 Female

0.58 [0.03-12]

0.729

   

 Age

1.1 [0.97-1.2]

0.168

   

 Personality disorders

190 [1.1-3200]

0.045

   

 Triglycerides

7.8 [1.6-37]

0.010

   

 Lack of insight

29 [1.5-570]

0.025

   

 Victims of violence

19 [1.2-320]

0.036

   

 Hopelessness

12 [0.69-240]

0.087

   

 Inpatient DSH

63 [0.88-4600]

0.058

   

Increase from step 1 (hopelessness, victims of violence,lack of insight, inpatient DSH)

  

29 (4)

<0.001

17-31%

Total variance of step 2

  

62 (8)

<0.001

41-75%

Step 3

     

 Female

13 [0.59-280]

0.353

   

 Age

1.2 [0.97-1.5]

0.089

   

 Personality disorders

1100 [0.36-34x106]

0.087

   

 Triglycerides

102 [0.76-14000]

0.064

   

 Victims of violence

2500 [0.52-12x106]

0.070

   

 Lack of insight

2600 [0.52-13x106]

0.071

   

 Hopelessness

1.4 [0.02-98]

0.872

   

 Inpatient DSH

1.1 [0.003-360]

0.978

   

 Self-report risk scale

0.51 [0.02-15]

0.699

   

 MINI suicidal scale

4.7 [0.99-22]

0.051

   

Increase from step 2 (by MINI and self-report risk scale)

  

12 (2)

0.003

6-10%

Total variance of step 3

  

74 (10)

<0.001

47-85%

DSH, deliberate self-harm.

a“pseudo R2” = Cox & Snell R2 – Nagelkerke R2 estimates (of the factors’ contribution to the total variance).

In the 12-month block-entry regression with the same 10 factors and 1-2 DSH as the inclusion criteria for the reference group (versus non-DSH patients in the previous analysis), PD (OR [95% CI] = 9.2 [1.9-44], p = 0.006) and TG (2.5 [1.1-5.5], p = 0.022) were the only significant variables in Step 1. Inpatient DSH (29 [1.0-820], p = 0.047) and TG (3.1 [1.0-9.3], p = 0.049) were significant in Step 2, and lack of insight (28 [1.0-760], p = 0.047) and TG (3.7 [1.0-13], p = 0.046) were significant in Step 3.

Similar results were obtained in the block-entry regression analysis at 3 months post-discharge of DSH patients. High TG level was the only significant factor in the third step of the stepwise regression when non-DSH patients were used as the reference group, with an OR [95% CI] of 7.5 [1.0-55] (p = 0.048). No factors were significant in the 3. step of the multiple regression analysis when 1-2 DSH patients (within 3 months after discharge) were the reference group. The TG value in the third step was 3.5 [0.67-18] (p = 0.156).

No significant correlations were found between TG and the main diagnostic groups. Furthermore, the results did not change when controlling for diagnoses of diabetes or alcohol misuse and for current medication at the time of admission. Only 1 of the DSH patients was recorded as having a diagnosis of heart disease.

Other predictive values

Finally, to further test possible incremental validity, TG levels were entered into the analysis together with positive MINI items (coded 0-6), female gender (coded 0, 1), PD (coded 0, 1), a lack of insight (coded 0, 1), violent victimization (coded 0, 1), and SRS (coded 0, 1). TG levels were coded as follows: 0-25th percentile = 2, 26th-50th percentile = 1, and 51st-100th percentile = 0. The ROC-AUC values associated with the 1-year follow-up for the 1-2 DSH and DSH-R groups are displayed in Table 4.
Table 4

The area under the curve of the receiver operator characteristic (AUC) for one-year DSH-R

 

Compared with non-DSH

Compared with 1-2-DSH

 

AUC [95% CI]

p

AUC [95% CI]

p

TG

0.74 [0.61-0.86]

0.001

0.69 [0.55-0.83]

0.017

SRS

0.77 [0.65-0.88]

<0.001

0.68 [0.54-0.81]

0.027

MINI Suicidal Scale

0.81 [0.72-0.91]

<0.001

0.62 [0.48-0.75]

0.146

Other variables (OV)a

0.86 [0.74-0.97)]

<0.001

0.81 [0.69-0.93)]

<0.001

MINI + TG

0.85 [0.77-0.94]

<0.001

0.71 [0.57-0.85]

0.009

MINI + OV

0.89 [0.80-0.98]

<0.001

0.76 [0.64-0.89]

0.001

OV + TG

0.89 [0.82-0.97]

<0.001

0.87 [0.77-0.96]

<0.001

MINI + OV + SRS + TG

0.91 [0.83-0.99]

<0.001

0.82 [0.70-0.94]

<0.001

OV + SRS + TG

0.92 [0.85-0.98]

<0.001

0.88 [0.79-0.97]

<0.001

DSH = deliberate self-harm; DSH-R = repeated DSH; SRS = Self-report Risk Scale; TG = triglycerides;

aFemale, personality disorder, victims of violence, lack of insight.

Other predictive values are displayed in Table 5. The cut-off values shown in Table 5 were based on the coordinates of all of the recorded sensitivities/specificities. For both models, the cut-off values constituted the largest sum of the sensitivity + specificity.
Table 5

Comparison of predictive values and likelihood ratios for the MINI and the MINI + OV a + SRS + TG for DSH-R patients

 

Cut off

Sens

Spec

PPV

NPV

NNA

LR+

LR-

MINI (0-6)

3.5

0.78

0.75

0.30

0.96

3.3

2.9

0.24

MINI + OVa + SRS + TG (0-14)

8.5

0.78

0.92

0.64

0.96

1.6

9.8

0.24

MINI = the MINI Suicidal Scale; OV = other significant variables; SRS = Self-report Scale; TG = triglycerides; Sens = sensitivity; Spec = specificity; PPV = positive predictive value; NPV = negative predictive value; NNA = number needed to assess; LR+ = positive likelihood ratio; LR- = negative likelihood ratio.

aFemale, personality disorders, victims of violence, lack of insight.

Discussion

The main finding of the present study was that TG showed significant incremental validity in the risk assessment of DSH-R at 3 and 12 months after discharge. The applied bio-psychosocial approach, including the MINI Suicidal Scale, psychosocial risk factors, and TG, produced a PPV that was twice as high as that obtained using the MINI alone. Furthermore, TG enhanced the predictive validity of DSH when comparing DSH-R patients with 1-2 DSH patients. One possible explanation for this finding is that an elevated TG level reflects stress activation in the noradrenergic nervous system. Studies have shown that psychological distress can lead to increased TG levels [2729]. The increase in TG following psychological distress results from direct psychological sympathetic activation and is not a metabolic effect [30]. Elevated TG levels have also been associated with general anxiety disorders [31]. Albrink et al. found a significant positive association between TG and obesity [32]. Stress has been identified as a common factor in obese individuals, and the neurobiology of stress overlaps significantly with that of appetite and energy regulation [33]. However, measurements of lipid levels after admission may not accurately reflect the lipid levels occurring prior to self-harm actions following discharge. Thus, monitoring TG levels near the time of stress exposure may improve the detection of this association.

Although there were no apparent differences in the risk of stress exposure between the 3 groups examined in this study at discharge, the DSH-R patients may have had a lower stress tolerance or less efficient coping skills. A lack of insight may contribute to increased vulnerability and a reduced ability to avoid stressful situations, which may also be the case for individuals with unstable personality disorders [34]. Furthermore, stress or stress-related conditions or symptoms or the risk of exposure to future stressful situations may have been ignored by hospital staff when rating the “risk of stress exposure” (V10) at discharge. Identifying a subgroup with a high risk of self-harm resulting from increased psychological distress may be of clinical importance both for treatment (coping with and reducing internal stress) and prevention (reducing external environmental stress). Regarding prevention, during the 1-year follow-up, victimization was increased in the DSH-R group compared with the other subgroups, indicating increased stress exposure, stress reactions, and stress vulnerability, which is in agreement with earlier reports of an association between victimization and DSH [35, 36].

Although depression and psychosis are strong risk factors for self-harm [1], these factors were significantly underrepresented in the DSH-R group and in all self-harming patients in this study [3]. However, several factors may explain these results: (i) there was a high prevalence of self-harm in this study; (ii) patients with depression or psychoses are known to be at self-harm risk, and these patients were not discharged before the risk was considered low and these patients may have received sufficient treatment and self-harm monitoring after being discharged; and (iii) patients with alcohol abuse or personality disorders and repeated admissions may have been treated inadequately, or co-morbidity may have been overlooked, in which case self-harm risk may have been ignored [37].

Previous studies revealed a negative correlation between body mass index (BMI) and suicide [38, 39]. However, one recent investigation conducted in Taiwan demonstrated increased suicide risk in both underweight and obese individuals [40]. Thus, the interpretation and understanding of this association are still inadequate. A greater body weight reduces the fatality of poisoning and shifts suicidal acts away from lethal means such as hanging, but it remains difficult to exclude other possible explanations for the reported correlation, such as psychiatric disorders that could lead to weight loss and suicidal ideation [41], including depression or anorexia. Our finding of an association between high TG and DSH-R is contrary to the BMI-related “protective” effect but concurs with results of studies that have found a potentially positive association between obesity and stress [33].

Other research has addressed the importance of focusing on high sensitivity in screening for self-harm repeaters in emergency settings [7]. The direct clinical application of AUC and OR values can be difficult. Other predictive values may add important information regarding the clinical applicability of screening tools. For most risk assessment instruments, the identification of individuals at risk is acceptable (high sensitivity), but the total predictive value is often low, with many false positives (low specificity). Compared with the MINI Suicidal Scale, the applied multifaceted bio-psychosocial screening method exhibited increased specificity, as demonstrated by a decrease in NNA values from 3.3 to 1.6. This finding indicates an increased positive predictive value and implies that a total of 2.3 or 0.6 patients, respectively, would have been unnecessarily assessed for DSH-R risk for every true DSH-R patient identified. The increase in the positive likelihood ratio from 2.9 to 9.8 indicates that a positive MINI test result increases the likelihood of a patient exhibiting DSH-R by 2.9-fold, whereas the increase in likelihood is 9.8-fold for a positive bio-psychosocial test. Our results suggest that easily accessible bio-psychosocial risk factors could be employed to screen for DSH risk in emergency settings.

Limitations

Only one hospital was involved in the present work, and the study sample was small, consisting of 40% of the potential subjects. There were some differences between the study sample and the other patients (non-consenting patients and patients lost to follow-up). Moreover, our sample of DSH-R patients was small, and the study population was selective relative to the community cohorts included in various BMI studies [38, 39]. These factors limit the generalizability of the obtained results. However, there was a higher incidence of self-harm-related variables in the follow-up sample. Records of self-harm behavior can be difficult to obtain and may suffer from under-reporting. Although the raters (baseline variables) and recorders (outcome variables) involved in the present study were responsible for different parts of the research, they all worked in the same clinical department. While the recorders were blinded to the baseline measures and ratings, there may still have been some communication that could have threatened the ideal performance of independent measurements. However, the clinicians’ familiarity with the patients may have counteracted the underreporting of self-harm episodes. Somatic illnesses that may influence lipid levels, such as heart disease and diabetes, could have been underreported in the psychiatric records, even though the patients were treated during their stay in the ward.

Alcohol consumption, cigarette smoking, and obesity increase TG levels [32, 4244]. Beyond recording the ICD-10 diagnosis of alcohol abuse, these factors were not controlled for in the study. However, smoking decreases BMI and counteracts the alcohol-related increase in TG levels (Wannamethee & Shaper, 1992), and there is no available evidence of interaction effects between alcohol use, smoking, and BMI in relation to suicide risk [40]. We did not control for dietary patterns or stress-related dietary changes, such as high carbohydrate intake, that may have caused elevated TG levels [33, 45], and no anxiety scales or tools were used in the study beyond the diagnosis of anxiety disorders.

Conclusions

In summary, TG levels explained variability in self-harming behavior that was not explained by the other risk factors assessed. This finding may help to identify a subgroup of patients characterized by repeated self-harming behavior. Thus, a bio-psychological approach appears to be promising, at least for high-risk subgroups. Further studies controlling for anxiety and stress-related measures, obesity measures, and alcohol consumption and smoking patterns are necessary to further develop and validate this model.

Abbreviations

BMI: 

Body mass index

CI: 

Confidence interval

DSH: 

Deliberate self-harm

ICD-10: 

International classification of diseases – version 10

LR: 

Likelihood ratio

MINI: 

The MINI international neuropsychiatric interview

NSSI: 

Non-suicidal self-injury

OR: 

Odds ratio

PPV: 

Positive predictive value

ROC-AUC: 

Area under the curve of the receiver operator characterstic

SRS: 

Self-report Risk Scale

TG: 

Triglycerides.

Declarations

Acknowledgements

We thank the staff at the Psychiatric Department, Aalesund Hospital, for data recording and collection. We also thank Bjørn Østberg and Mona Skjønberg at the Centre of Research and Education in Forensic Psychiatry, Oslo University Hospital, Norway for valuable help and support.

Authors’ Affiliations

(1)
Psychiatric Department, Ålesund Hospital, Møre & Romsdal Health Trust
(2)
Institute of Neuromedicine, Faculty of Medicine, The Norwegian University of Science and Technology
(3)
Centre for Research and Education in Forensic Psychiatry, Oslo University Hospital
(4)
Psychiatric Department, Trondheim University Hospital
(5)
Institute of Health and Social Sciences, Molde University College

References

  1. Hawton K, van Heeringen K: Suicide. Lancet. 2009, 373 (9672): 1372-1381. 10.1016/S0140-6736(09)60372-X.View ArticlePubMedGoogle Scholar
  2. Bryan CJ, Rudd MD: Advances in the assessment of suicide risk. J Clin Psychol. 2006, 62 (2): 185-200. 10.1002/jclp.20222.View ArticlePubMedGoogle Scholar
  3. Roaldset JO, Linaker OM, Bjørkly S: Predictive validity of the MINI suicidal scale for self-harm in acute psychiatry: a prospective study of the first year after discharge. Arch Suicide Res. 2012, 16 (4): 287-302. 10.1080/13811118.2013.722052.View ArticlePubMedGoogle Scholar
  4. Blasco-Fontecilla H, Delgado-Gomez D, Ruiz-Hernandez D, Aguado D, Baca-Garcia E, Lopez-Castroman J: Combining scales to assess suicide risk. J Psychiatr Res. 2012, 46 (10): 1272-1277. 10.1016/j.jpsychires.2012.06.013.View ArticlePubMedGoogle Scholar
  5. Mellesdal L, Mehlum L, Wentzel-Larsen T, Kroken R, Jorgensen HA: Suicide risk and acute psychiatric readmissions: a prospective cohort study. Psychiatr Serv. 2010, 61 (1): 25-31.View ArticlePubMedGoogle Scholar
  6. Waern M, Sjöström N, Marlow T, Hetta J: Does the suicide assessment scale predict risk of repetition? A prospective study of suicide attempters at a hospital emergency department. Eur Psychiatr. 2010, 25 (7): 421-426. 10.1016/j.eurpsy.2010.03.014.View ArticleGoogle Scholar
  7. Bilén K, Ponzer S, Ottosson C, Castrén M, Owe-Larsson B, Ekdahl K, Pettersson H: Can repetition of deliberate self-harm be predicted? A prospective multicenter study validating clinical decision rules. J Affect Disord. 2013, 149 (1-3): 253-258. 10.1016/j.jad.2013.01.037.View ArticlePubMedGoogle Scholar
  8. Carballo JJ, Akarnnonu CP, Oquendo MA: Neurobiology of suicidal behavior. An integration of biological and clinical findings. Arch Suicide Res. 2008, 12 (2): 93-110. 10.1080/13811110701857004.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Mann JJ: Neurobiology of suicidal behaviour. Nat Rev Neurosci. 2003, 4 (10): 819-828.View ArticlePubMedGoogle Scholar
  10. Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP: Can biological tests assist prediction of suicide in mood disorders?[erratum appears in Int J Neuropsychopharmacol. 2006 Dec;9(6):777]. Int J Neuropsychopharmcol. 2006, 9 (4): 465-474. 10.1017/S1461145705005687.View ArticleGoogle Scholar
  11. Coryell W, Schlesser M: Combined biological tests for suicide prediction. Psychiatry Res. 2007, 150 (2): 187-191. 10.1016/j.psychres.2006.01.021.View ArticlePubMedPubMed CentralGoogle Scholar
  12. O'Donovan A, Rush G, Hoatam G, Hughes BM, McCrohan A, Kelleher C, O'Farrelly C, Malone KM: Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anxiety. 2013, 30 (4): 307-314. 10.1002/da.22087.View ArticlePubMedGoogle Scholar
  13. Kunugi H, Takei N, Aoki H, Nanko S: Low serum cholesterol in suicide attempters. Biol Psychiatry. 1997, 41 (2): 196-200. 10.1016/S0006-3223(95)00672-9.View ArticlePubMedGoogle Scholar
  14. Peres-Rodriguez B-G, Diaz-Sastre G-R, Ceverino S-R, Leon O: Low serun cholesterol may be associated with suicide attempt history. J Clin Psycihiatr. 2008, 69 (12): 1920-1927. 10.4088/JCP.v69n1210.View ArticleGoogle Scholar
  15. Deisenhammer EA, Lechner-Schoner T, Kemmler G, Ober A, Braidt E, Hinterhuber H: Serum lipids and risk factors for attempted suicide in patients with alcohol dependence. Alcohol Clin Exp Res. 2006, 30 (3): 460-465. 10.1111/j.1530-0277.2006.00050.x.View ArticlePubMedGoogle Scholar
  16. Olie E, Picot MC, Guillaume S, Abbar M, Courtet P: Measurement of total serum cholesterol in the evaluation of suicidal risk. J Affect Disord. 2011, 133 (1–2): 234-238.View ArticlePubMedGoogle Scholar
  17. Deisenhammer EA, Kramer-Reinstadler K, Liensberger D, Kemmler G, Hinterhuber H, Fleischhacker W: No evidence for an association between serum cholesterol and the course of depression and suicidality. Psychiatry Res. 2004, 121 (3): 253-261. 10.1016/j.psychres.2003.09.007.View ArticlePubMedGoogle Scholar
  18. Fiedorowicz JG, Coryell WH: Cholesterol and suicide attempts: a prospective study of depressed inpatients. Psychiatry Res. 2007, 152 (1): 11-20. 10.1016/j.psychres.2006.09.003.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Roaldset JO, Bakken AM, Bjørkly S: A prospective study of lipids and serotonin as risk markers of violence and self-harm in acute psychiatric patients. Psychiatry Res. 2011, 186 (2–3): 293-299.View ArticlePubMedGoogle Scholar
  20. Roaldset JO, Bjørkly S: Patients' own statements of their future risk for violent and self-harm behaviour: a prospective inpatient and post-discharge follow-up study in an acute psychiatric unit. Psychiatry Res. 2010, 178 (1): 153-159. 10.1016/j.psychres.2010.04.012.View ArticlePubMedGoogle Scholar
  21. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998, 59 (Suppl 20): 22-33. quiz 34-57PubMedGoogle Scholar
  22. Roaldset JO, Hartvig P, Bjørkly S: V-RISK-10: Validation of a screen for risk of violence after discharge from acute psychiatry. Eur Psychiatr. 2011, 26 (2): 85-91. 10.1016/j.eurpsy.2010.04.002.View ArticleGoogle Scholar
  23. Weishaar ME, Beck AT: Hopelessness and suicide. Int Rev Psychiatr. 1992, 4 (2): 177-184. 10.3109/09540269209066315.View ArticleGoogle Scholar
  24. Klonsky ED: The functions of deliberate self-injury: a review of the evidence. Clin Psychol Rev. 2007, 27 (2): 226-239. 10.1016/j.cpr.2006.08.002.View ArticlePubMedGoogle Scholar
  25. Silverman MM, Berman AL, Sanddal ND, O'Carroll PW, Joiner TE: Rebuilding the tower of Babel: a revised nomenclature for the study of suicide and suicidal behaviors. Part 2: Suicide-related ideations, communications, and behaviors. Suicide Life Threat Behav. 2007, 37 (3): 264-277. 10.1521/suli.2007.37.3.264.View ArticlePubMedGoogle Scholar
  26. Deeks JJ, Altman DG: Diagnostic tests 4: likelihood ratios.[comment]. BMJ. 2004, 329 (7458): 168-169. 10.1136/bmj.329.7458.168.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Maimanee TA: The impact of exams anxiety on the level of triglycerides in university female students. J Egypt Soc Parasitol. 2010, 40 (1): 259-270.PubMedGoogle Scholar
  28. Agarwal V, Gupta B, Singhal U, Bajpai SK: Examination stress: changes in serum cholesterol, triglycerides and total lipids. Indian J Physiol Pharmacol. 1997, 41 (4): 404-408.PubMedGoogle Scholar
  29. Chikani V, Reding D, Gunderson P, McCarty CA: Wisconsin rural women's health study psychological factors and blood cholesterol level: difference between normal and overweight rural women. Clin. 2004, 2 (1): 47-53.Google Scholar
  30. Bachen EA, Muldoon MF, Matthews KA, Manuck SB: Effects of hemoconcentration and sympathetic activation on serum lipid responses to brief mental stress. Psychosom Med. 2002, 64 (4): 587-594. 10.1097/01.PSY.0000021943.35402.8A.PubMedGoogle Scholar
  31. Kuczmierczyk AR, Barbee JG, Bologna NA, Townsend MH: Serum cholesterol levels in patients with generalized anxiety disorder (GAD) and with GAD and comorbid major depression. Can J Psychiatr Rev Can Psychiatr. 1996, 41 (7): 465-468.Google Scholar
  32. Albrink MJ, Krauss RM, Lindgren FT, Groeben J, Pan S, Wood PD: Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population. Lipids. 1980, 15 (9): 668-676. 10.1007/BF02534017.View ArticlePubMedGoogle Scholar
  33. Sinha R, Jastreboff AM: Stress as a common risk factor for obesity and addiction. Biol Psychiatry. 2013, 73 (9): 827-835. 10.1016/j.biopsych.2013.01.032.View ArticlePubMedPubMed CentralGoogle Scholar
  34. May AM, Klonsky ED, Klein DN: Predicting future suicide attempts among depressed suicide ideators: a 10-year longitudinal study. J Psychiatr Res. 2012, 46 (7): 946-952. 10.1016/j.jpsychires.2012.04.009.View ArticlePubMedPubMed CentralGoogle Scholar
  35. Fisher HL, Moffitt TE, Houts RM, Belsky DW, Arseneault L, Caspi A: Bullying victimisation and risk of self harm in early adolescence: longitudinal cohort study. BMJ (Clin Res Ed). 2012, 344: e2683-Google Scholar
  36. Noll JG, Horowitz LA, Bonanno GA, Trickett PK, Putnam FW: Revictimization and self-harm in females who experienced childhood sexual abuse: results from a prospective study. J Interpers Violence. 2003, 18 (12): 1452-1471. 10.1177/0886260503258035.View ArticlePubMedGoogle Scholar
  37. Boenisch S, Bramesfeld A, Mergl R, Havers I, Althaus D, Lehfeld H, Niklewski G, Hegerl U: The role of alcohol use disorder and alcohol consumption in suicide attempts-a secondary analysis of 1921 suicide attempts. Eur Psychiatr. 2010, 25 (7): 414-420. 10.1016/j.eurpsy.2009.11.007.View ArticleGoogle Scholar
  38. Bjerkeset O, Romundstad P, Evans J, Gunnell D, Bjerkeset O, Romundstad P, Evans J, Gunnell D: Association of adult body mass index and height with anxiety, depression, and suicide in the general population: the HUNT study. Am J Epidemiol. 2008, 167 (2): 193-202.View ArticlePubMedGoogle Scholar
  39. Magnusson PKE, Rasmussen F, Lawlor DA, Tynelius P, Gunnell D: Association of body mass index with suicide mortality: a prospective cohort study of more than one million men. Am J Epidemiol. 2006, 163 (1): 1-8.View ArticlePubMedGoogle Scholar
  40. Chang S-S, Wen CP, Tsai MK, Lawlor DA, Yang YC, Gunnell D: Adiposity, its related biologic risk factors, and suicide: a cohort study of 542,088 Taiwanese adults. Am J Epidemiol. 2012, 175 (8): 804-815. 10.1093/aje/kwr386.View ArticlePubMedGoogle Scholar
  41. de Leon J, Mallory P, Maw L, Susce MT, Perez-Rodriguez MM, Baca-Garcia E: Lack of replication of the association of low serum cholesterol and attempted suicide in another country raises more questions. Ann Clin Psychiatry. 2011, 23 (3): 163-170.PubMedGoogle Scholar
  42. Wannamethee G, Shaper AG: Blood lipids: the relationship with alcohol intake, smoking, and body weight. J Epidemiol Community Health. 1992, 46 (3): 197-202. 10.1136/jech.46.3.197.View ArticlePubMedPubMed CentralGoogle Scholar
  43. Willett W, Hennekens CH, Castelli W, Rosner B, Evans D, Taylor J, Kass EH: Effects of cigarette smoking on fasting triglyceride, total cholesterol, and HDL-cholesterol in women. Am Heart J. 1983, 105 (3): 417-421. 10.1016/0002-8703(83)90358-7.View ArticlePubMedGoogle Scholar
  44. Freeman DJ, Griffin BA, Murray E, Lindsay GM, Gaffney D, Packard CJ, Shepherd J: Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest. 1993, 23 (10): 630-640. 10.1111/j.1365-2362.1993.tb00724.x.View ArticlePubMedGoogle Scholar
  45. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK: Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest. 1999, 104 (8): 1087-1096. 10.1172/JCI6572.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-244X/14/54/prepub

Copyright

© Roaldset et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

Advertisement